Please try another search
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms. The company develops AVA6000, FAPa-activated doxorubicin that is in Phase I clinical trial for treating locally advanced or metastatic-selected solid tumors; AVA3996, a tumor-targeted proteasome inhibitor based on bortezomib; AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing LR19128 PD-L1 XT; and collaboration and license agreement with Avacta and Daewoong Pharmaceutical Co. Ltd. for developing AFX-001 for solid organ transplant and graft vs host Disease, and AFX-002 for multiple sclerosis. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
David Alastair Smith | - | 2005 | CEO & Executive Director |
Tony Gardiner | 50 | 2016 | CFO, Company Secretary & Executive Director |
Eliot Richard Forster | 56 | 2018 | Independent Non-Executive Chairman |
Trevor J. Nicholls | 66 | 2013 | Independent Non-Executive Director |
Mark A. Goldberg | 69 | 2021 | Independent Non-Executive Director |
Krishna Komanduri | - | 2021 | Member of Scientific Advisory Board |
Stephane Champiat | - | 2021 | Member of Scientific Advisory Board |
Shaun Edward Chilton | 55 | 2023 | Non-Executive Director |
Paul Andrew Fry | 56 | 2020 | Independent Non-Executive Director |
James Spicer | - | 2021 | Member of Scientific Advisory Board |
Christina Marie Coughlin | 54 | 2022 | Head of Research & Development, Interim Chief Medical Officer and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review